Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET)
Top Cited Papers
- 28 August 2001
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (19) , 10966-10971
- https://doi.org/10.1073/pnas.191044198
Abstract
Neuropathology studies show that patients with mild cognitive impairment (MCI) and Alzheimer9s disease typically have lesions of the entorhinal cortex (EC), hippocampus (Hip), and temporal neocortex. Related observations with in vivo imaging have enabled the prediction of dementia from MCI. Although individuals with normal cognition may have focal EC lesions, this anatomy has not been studied as a predictor of cognitive decline and brain change. The objective of this MRI-guided 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) study was to examine the hypothesis that among normal elderly subjects, EC METglu reductions predict decline and the involvement of the Hip and neocortex. In a 3-year longitudinal study of 48 healthy normal elderly, 12 individuals (mean age 72) demonstrated cognitive decline (11 to MCI and 1 to Alzheimer9s disease). Nondeclining controls were matched on apolipoprotein E genotype, age, education, and gender. At baseline, metabolic reductions in the EC accurately predicted the conversion from normal to MCI. Among those who declined, the baseline EC predicted longitudinal memory and temporal neocortex metabolic reductions. At follow-up, those who declined showed memory impairment and hypometabolism in temporal lobe neocortex and Hip. Among those subjects who declined, apolipoprotein E E4 carriers showed marked longitudinal temporal neocortex reductions. In summary, these data suggest that an EC stage of brain involvement can be detected in normal elderly that predicts future cognitive and brain metabolism reductions. Progressive E4-related hypometabolism may underlie the known increased susceptibility for dementia. Further study is required to estimate individual risks and to determine the physiologic basis for METglu changes detected while cognition is normal.Keywords
This publication has 45 references indexed in Scilit:
- Tracking Alzheimerʼs disease in transgenic mice using fluorodeoxyglucose autoradiographyNeuroReport, 2000
- Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆Neurobiology of Aging, 2000
- Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PETBrain, 1999
- Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers diseaseJournal of Psychiatric Research, 1999
- High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary ChangesExperimental Neurology, 1998
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Pattern of Cerebral Metabolic Interactions in a Subject with Isolated Amnesia at Risk for Alzheimer's Disease: A Longitudinal EvaluationDementia and Geriatric Cognitive Disorders, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioningIEEE Transactions on Medical Imaging, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984